NCT03849651
- Conditions
- Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Bone Marrow Diseases, +33 more
- Locations
-
- St. Jude Children's Research Hospital Memphis, Tennessee, United States
Clinical trial condition
Immunoproliferative Disorders
Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.
10,001 public trials
2,038 recruiting studies
Immunoproliferative Disorders trial results
NCT05083169
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- University of Alabama Birmingham Birmingham, Alabama, United States
- City of Hope Duarte, California, United States
- Stanford University Medical Center Stanford, California, United States
- Yale University New Haven, Connecticut, United States
Active, not recruiting
A Study of Belantamab Mafodotin in Combination With Nirogacestat and Pomalidomide in People With Multiple Myeloma That Has Not Responded to Treatment or Has Come Back After Treatment
NCT05556798
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
- Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activities) Commack, New York, United States
Active, not recruiting
Effect of 10 mg Xanamem on Dementia Due to Alzheimer's Disease
NCT06125951
- Conditions
- Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +18 more
- Locations
-
- ACW Investigative Site 218 Carlsbad, California, United States
- ACW Investigative Site 209 Sherman Oaks, California, United States
- ACW Investigative Site 211 Denver, Colorado, United States
- ACW Investigative Site 208 Englewood, Colorado, United States
Active, not recruiting
A Phase II Study of Ibrutinib Plus FCR in Previously Untreated, Younger Patients With Chronic Lymphocytic Leukemia
NCT02251548
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
- Locations
-
- University of Miami Sylvester Comprehensive Cancer Center Coral Gables, Florida, United States
- University of Miami Sylvester Comprehensive Cancer Center Deerfield Beach, Florida, United States
- Unversity of Miami Sylvester Comprehensve Cancer Center Miami, Florida, United States
- University of Kansas Cancer Center Westwood, Kansas, United States
Active, not recruiting
Study of Safety and Efficacy of Iberdomide (CC-220) and CC-99282 Combined With R-CHOP to Treat Lymphoma
NCT04884035
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Local Institution - 162 Birmingham, Alabama, United States
- Local Institution - 154 Scottsdale, Arizona, United States
- Local Institution - 169 Duarte, California, United States
- Local Institution - 160 Jacksonville, Florida, United States
Active, not recruiting
A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies
NCT05589896
- Conditions
- Acute Biphenotypic Leukemia, Acute Leukemia, Acute Lymphoblastic Leukemia, +39 more
- Locations
-
- City of Hope Duarte, California, United States
- Moffitt Cancer Center Tampa, Florida, United States
- Emory University - Winship Cancer Institute Atlanta, Georgia, United States
- Henry Ford Cancer Institute Detroit, Michigan, United States
Active, not recruiting
Tafasitamab and Lenalidomide Followed by Tafasitamab and ICE as Salvage Therapy for Transplant Eligible Patients With Relapsed/ Refractory Large B-Cell Lymphoma
NCT05821088
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +30 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
Active, not recruiting
A Phase II Trial of Teclistamab in Participants With Previously Treated Immunoglobulin Light-chain (AL) Amyloidosis
NCT06649695
- Conditions
- AL Amyloidosis, Amyloidosis, Immune System Diseases, +10 more
- Locations
-
- South Australia Health Adelaide, Australia
- Westmead Hospital Sydney, Australia
- CHU Limoges Limoges, France
- University Hospital Essen Essen, Germany
Active, not recruiting
CB-839 HCl in Combination With Carfilzomib and Dexamethasone in Treating Patients With Recurrent or Refractory Multiple Myeloma
NCT03798678
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- Yale University New Haven, Connecticut, United States
- Moffitt Cancer Center Tampa, Florida, United States
- Mayo Clinic in Rochester Rochester, Minnesota, United States
- Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States